I must have read the wrong report. The one I saw basically said the same thing as last quarter, with yesterday's date on it. Yes, it went from 15 bucks to 2, but if your good news is that it hasn't gone from 2 to 35 cents...Yes, that is a good thing.
Yes... our dear Quon has lost a bit of credibility over the last couple of years, hasn't he.
I still read his articles, of course, but more with the acumen of a pensioner at the roulette wheel - hoping upon hope that perhaps his BB will at last fall into the right slot, and we'll all be able to marvel at his prophetic wisdom.
At some time, I think I will realize that a better analogy will be of a life guard who throws me ring after ring, only to find that each ring is bouyed only with sand.
"Today we are making products, not Power Point presentations."
Really looking forward to the earnings call, because previous Power Point presentations have been increasingly disappointing.
"We can convert sugar to oil in a couple of days. It doesn't have to be a decade long, multi-million dollar enterprise for us."
When does that "couple of days" begin, do you think? Because it has not yet occurred.
Also, when those rights are "granted", they haven't bought the shares yet. When they actually buy the shares, the report will say that the options have been "exercised".
They don't have to buy the shares, and they don't have to buy them all at one time. That is why they are "rights", or "options".
If they actually buy some or all of them, they have a window of time in which to do it or they expire.
Typically 70 % of a company's stock is held by institutional investors. SZYM: 30%. I imagine much of that is by folks who are holding for the big future or are stuck because they paid a lot compared to what it is worth. They ain't trading it until it becomes a solid promise. I think we have to wait until the products and sales mature and Moema gets their stuff together so they can produce it. Let's face it - a lot of folks bought this stock on the promise of groundbreaking technology and saving the world (I did!), and that hasn't paid off yet. It might, but we're learning is what is common sense: you can't decide to grow pumpkins this morning and eat pumpkin pie this afternoon.
That sounds wonderful; it would be good to hear Solazyme verify it. Without verification, I am just interested in the fishing.
I'm not sure that earnings by themselves are going to tell a story. I fully expect that there will be losses, particularly with the extraordinary charges. What I am hoping to hear is progress on the Moema debacle and some concrete sales improvement. I would like to hear sales and future sales estimates broken down by business line, but I suppose that is asking a bit much.
Even if there is a very good report, I do not expect the stock price to increase, because sales may be influenced only by the retail market. Institutional buyers will want to get a little more consistency under their belts before they nibble on this hook again.
I am well aware of SZYM's poor record of communication. "...more volume by now if the news was good" implies that some news has gotten out some how, some way. I have not heard any such news, and that is the purpose of my question. trrjaws was polite enough to answer my question civilly, and I appreciate it. Your monosyllabic pejoratives however, reinforce the reason why adoption by caring and loving parents is so important.
When somebody buys 143,000 shares in one swell foop, that's institutional buying, right? Or is it just a whole bunch of retail long losers get a bee in their bonnets all at the same time?
Frequently takes more time to prepare for the annual report than the quarterlies - not just for SZYM, but for other companies, too. By the way, SZYM just announced the conference call will be on February 26.
Are you referring to Encapso or sales in general? Because I see 14Q3 product sales of $11.623 MM vs 13Q3 of $4.797 MM, but I don't see any figures for specific products or lines.
Never mind the price of oil... What would be good for Solazyme would be to get Moema crackin' and show that they can make some money.
Solazyme started out being a replacement for fossil fuels. I thought that was kind of cool if you owned a backyard fermenting unit, but as a competitor for Exxon or BP... I kind of think not. However, when they put fuel on the back burner and focused instead on specialty oils, that became a game-changer in my mind. Their execution has been poor, but if they ever figure out where to plug in an extension cord and how to sell some of their products, then we have something. You might be right about them heading for the end. I'm on pins and needles, and I hope you have to eat some crow - the sooner the better.
In case you did not read it clearly, those "acquisitions" were options granted to purchase SZYM at no cost to the executives listed.
Although Solazyme has developed fuel products that work well, the direction of the company has changed dramatically. There is much higher profit in food, cosmetic, and other applications of Solazyme products, and they are focusing on the lower volume, higher profit products, at least until they can produce at decent volumes.
Sure would like to hear frequent (e.g., monthly) reports on how they are progressing along those lines, though.
Seems to me that building a plant without a stable power source is like buying a car without a gas tank...It seems rather incredulous.